Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-11 11:36 am Sale | 13G | REPARE THERAPEUTICS INC RPTX | CHI Advisors LLC | 2,212,256 5.3% | -319,894 (-12.63%) | View |
2022-02-09 1:48 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | ARK Investment Management LLC | 2,980,836 7.14% | 2,980,836 (New Position) | View |
2022-02-09 10:24 am Purchase | 13G | REPARE THERAPEUTICS INC RPTX | FMR LLC | 3,021,313 7.239% | 263,938 (+9.57%) | View |
2021-11-02 5:01 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | ORBIMED ADVISORS LLC | 3,177,041 7.7% | -99,284 (-3.03%) | View |
2021-10-29 4:33 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | Deep Track Capital LP | 2,104,600 5.12% | 2,104,600 (New Position) | View |
2021-08-16 4:57 pm Unchanged | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 2,594,451 7% | 0 (Unchanged) | View |
2021-07-20 5:36 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | MPM BioVentures 2014 L.P. | 3,882,485 10.5% | -396,746 (-9.27%) | View |
2021-05-25 4:06 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | MPM BioVentures 2014 L.P. | 4,279,231 11.6% | -393,607 (-8.42%) | View |
2021-03-22 5:49 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | MPM BioVentures 2014 L.P. | 4,672,838 12.7% | -719,271 (-13.34%) | View |
2021-03-16 5:18 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 3,722,398 10.1% | 750,207 (+25.24%) | View |
2021-03-02 2:53 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | CHI Advisors LLC | 2,532,150 6.9% | 2,532,150 (New Position) | View |
2021-02-26 4:36 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 2,594,451 7.1% | -550,000 (-17.49%) | View |
2021-02-16 4:27 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | Redmile Group LLC | 2,647,696 7.2% | 2,647,696 (New Position) | View |
2021-02-12 4:22 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 2,972,191 8.1% | 1,027,645 (+52.85%) | View |
2021-02-08 10:31 am Purchase | 13G | REPARE THERAPEUTICS INC RPTX | FMR LLC | 2,757,375 7.499% | 2,757,375 (New Position) | View |
2021-01-25 4:27 pm Sale | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 3,144,451 8.6% | -275,000 (-8.04%) | View |
2020-07-06 9:31 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | Versant Venture Capital V L.P. | 3,419,451 9.3% | 3,419,451 (New Position) | View |
2020-07-06 4:06 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | MPM BioVentures 2014 L.P. | 5,392,109 14.7% | 5,392,109 (New Position) | View |
2020-06-29 6:25 pm Purchase | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 1,944,546 5.3% | 1,944,546 (New Position) | View |
2020-06-25 8:19 pm Purchase | 13D | REPARE THERAPEUTICS INC RPTX | ORBIMED ADVISORS LLC | 3,276,325 8.9% | 3,276,325 (New Position) | View |